JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB76199

Anti-eNOS (phospho S632) antibody [M232]

Be the first to review this product! Submit a review

|

(16 Publications)

Mouse Monoclonal eNOS phospho S632 antibody. Suitable for WB and reacts with Human samples. Cited in 16 publications. Immunogen corresponding to Synthetic Peptide within Mouse Nitric oxide synthase, endothelial phospho S632.

View Alternative Names

Ecnos, Nitric oxide synthase 3, Constitutive NOS, EC-NOS, NOS type III, cNOS, NOSIII, Endothelial NOS, eNOS

2 Images
Western blot - Anti-eNOS (phospho S632) antibody [M232] (AB76199)
  • WB

Unknown

Western blot - Anti-eNOS (phospho S632) antibody [M232] (AB76199)

The 120 kDa band may be a truncated form of eNOS.

All lanes:

Western blot - Anti-eNOS (phospho S632) antibody [M232] (ab76199) at 1/500 dilution

Lane 1:

human umbilical vein endothelialcells, untreated

Lane 2:

human umbilical vein endothelialcells, treated with lambda phosphatase

Predicted band size: 133 kDa

Observed band size: 120 kDa,140 kDa

false

Western blot - Anti-eNOS (phospho S632) antibody [M232] (AB76199)
  • WB

CiteAb

Western blot - Anti-eNOS (phospho S632) antibody [M232] (AB76199)

eNOS (phospho S632) western blot using anti-eNOS (phospho S632) antibody [M232] ab76199. Publication image and figure legend from Gupta, A., Anjomani-Virmouni, S., et al., 2017, Mol Cell, PubMed 28306514.

ab76199 was used in this publication in western blot. This may not be the same as the application(s) guaranteed by Abcam. For a full list of applications guaranteed by Abcam for ab76199 please see the product overview.

PARK2 Depletion Leads to Enhanced S-nitrosylation and Ubiquitination of PTEN(A) Anti-PTEN immunoprecipitates (IP) derived from MYC-tagged-transfected PTEN HCT116 cells expressing GFP or PARK2 shRNA.(B) Fluorometric measurement of S-nitrosylated PTEN between shGFP and shPARK2 HCT116 cells. SNO-PTEN was assessed by NO release, causing the conversion of DAN to the fluorescent compound NAT (p = 0.009).(C and D) Immunoblot analysis of (C) whole-cell lysates and (D) anti-PTEN immunoprecipitates (IP) derived from HA-ubiquitin (Ub) and Myc-tagged PTEN-transfected HCT116 cells expressing GFP or PARK2 shRNA. Where indicated, cells were treated with MG132 (10 μM) for 6 hr before collection.(E–G) Immunoblot analysis and anti-PTEN immunoprecipitates derived from (E) Myc-tagged WT or C83S mutant PTEN-transfected HCT116 cells expressing GFP or PARK2 shRNA; (F) WT PTEN-transfected shGFP and shPARK2 HCT116 cells, 48 hr post-transfection with scrambled or AMPK α1 and AMPK α2 siRNAs; and (G) parental HCT116 treated (or not treated) with the allosteric AMPK activator 991 for 5 hr (20 μM) following 2 hr serum starvation (left) or with 25-mM glucose-containing DMEM (middle) for 6 hr or with oligomycin (5 μM) for 2 hr. Data are represented as mean ± SEM.See also Figures S5 and S6.

false

Key facts

Host species

Mouse

Clonality

Monoclonal

Clone number

M232

Isotype

IgG1

Carrier free

No

Reacts with

Human

Applications

WB

applications

Immunogen

Synthetic Peptide within Mouse Nitric oxide synthase, endothelial phospho S632. The exact immunogen used to generate this antibody is proprietary information.

P70313

Specificity

ab76199 is not expected to react with other NOS family members due to low homology.

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/500", "WB-species-notes": "<p></p>" }, "Rat": { "WB-species-checked": "predicted", "WB-species-dilution-info": "", "WB-species-notes": "" } } }

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Protein A
Storage buffer
Preservative: 0.05% Sodium azide Constituents: PBS, 50% Glycerol (glycerin, glycerine), 0.1% BSA
Shipped at conditions
Blue Ice
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Storage information
Stable for 12 months at -20°C

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

ENOS also known as endothelial nitric oxide synthase is an enzyme important for the production of nitric oxide (NO) in blood vessels. This protein with a molecular weight of approximately 133 kDa is expressed mostly in endothelial cells. eNOS plays a mechanical role in synthesizing NO from L-arginine a process requiring cofactors such as NADPH and oxygen. The activity of eNOS can be investigated through techniques such as Western blot with specific assays like phospho-eNOS ELISA available to measure its phosphorylated forms indicating activated states of the enzyme.
Biological function summary

ENOS contributes significantly to the regulation of vascular tone and blood flow by promoting vasodilation. It does not function alone; instead it forms complexes with other proteins to exert its full effect. eNOS activity influences the process of angiogenesis inflammation modulation and platelet aggregation. Through its ability to produce nitric oxide eNOS acts as a signaling molecule helping maintain vascular homeostasis.

Pathways

ENOS is a critical player in the NO signaling pathway and interacts intricately with the PI3K/Akt pathway. Nitric oxide produced by eNOS has a role in signaling cascades that lead to vascular dilation and reduced blood pressure. The PI3K/Akt pathway regulates eNOS activity via phosphorylation enhancing NO production. Other proteins like caveolin-1 and calmodulin modulate eNOS impacting these pathways' outcomes.

ENOS is associated with cardiovascular conditions like atherosclerosis and hypertension. Dysfunction of eNOS can lead to reduced NO production impairing vasodilation and contributing to these diseases. In cardiovascular disorders eNOS interacts with proteins such as the angiotensin II type 1 receptor which can negatively impact its function exacerbating disease states. Investigating eNOS and its related proteins provides insight into potential therapeutic targets for improving cardiovascular health.

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Produces nitric oxide (NO) which is implicated in vascular smooth muscle relaxation through a cGMP-mediated signal transduction pathway. NO mediates vascular endothelial growth factor (VEGF)-induced angiogenesis in coronary vessels and promotes blood clotting through the activation of platelets. May play a significant role in normal and abnormal limb development.
See full target information Nitric oxide synthase, endothelial phospho S632

Publications (16)

Recent publications for all applications. Explore the full list and refine your search

Frontiers in cardiovascular medicine 8:810477 PubMed35174224

2022

Endothelial Agrin Is Dispensable for Normal and Tumor Angiogenesis.

Applications

Unspecified application

Species

Unspecified reactive species

Peng Ye,Zelong Fu,Jeff Yat-Fai Chung,Xiaoyun Cao,Ho Ko,Xiao Yu Tian,Patrick Ming-Kuen Tang,Kathy O Lui

Cell cycle (Georgetown, Tex.) 20:1663-1680 PubMed34334119

2021

Inhibition of LOXL1-AS1 alleviates oxidative low-density lipoprotein induced angiogenesis via downregulation of miR-590-5p mediated KLF6/VEGF signaling pathway.

Applications

Unspecified application

Species

Unspecified reactive species

Xuan Cheng,Zhiwei Liu,Haifeng Zhang,Yajun Lian

Medical science monitor : international medical journal of experimental and clinical research 27:e928153 PubMed33770068

2021

Salvianic Acid A Regulates High-Glucose-Treated Endothelial Progenitor Cell Dysfunction via the AKT/Endothelial Nitric Oxide Synthase (eNOS) Pathway.

Applications

Unspecified application

Species

Unspecified reactive species

Yanhua Guan,Xu Wang

Pharmaceutical biology 58:165-175 PubMed32608342

2020

The protective effects of different compatibility proportions of the couplet medicines for Astragali Radix and Radix on myocardial infarction injury.

Applications

Unspecified application

Species

Unspecified reactive species

Lu Chen,Min Song,Lusha Zhang,Chunxiao Li,Zhirui Fang,Joel Wake Coffie,Liyuan Zhang,Lulu Ma,Leyu Fang,Qianyi Wang,Wenjie Yang,Fanggang Li,Xiumei Gao,Hong Wang

Medical science monitor : international medical jo 26:e919854 PubMed32027625

2020

Knockdown of Long Noncoding RNA (lncRNA) AK094457 Relieved Angiotensin II Induced Vascular Endothelial Cell Injury.

Applications

Unspecified application

Species

Unspecified reactive species

JiaYi Xu,Yingjie Sun,Jie Lu

Molecular medicine reports 17:1485-1492 PubMed29138836

2017

GATA4 protects against hyperglycemia‑induced endothelial dysfunction by regulating NOX4 transcription.

Applications

Unspecified application

Species

Unspecified reactive species

Hongfei Xu,Zhen Wang,Zewei Sun,Yiming Ni,Liangrong Zheng

Acta pharmacologica Sinica 39:97-106 PubMed28770825

2017

Kappa-opioid receptor agonist U50448H protects against renal ischemia-reperfusion injury in rats via activating the PI3K/Akt signaling pathway.

Applications

Unspecified application

Species

Unspecified reactive species

Li-Jie Liu,Jian-Jun Yu,Xiao-Lin Xu

Journal of cellular biochemistry 119:806-816 PubMed28657671

2017

Effects of astragalus polysaccharide on apoptosis of myocardial microvascular endothelial cells in rats undergoing hypoxia/reoxygenation by mediation of the PI3K/Akt/eNOS signaling pathway.

Applications

Unspecified application

Species

Unspecified reactive species

Qingling Zhou,Guowei Meng,Fei Teng,Qiang Sun,Yongshan Zhang

Cellular physiology and biochemistry : internation 42:506-518 PubMed28578351

2017

Protective Effects of MicroRNA-126 on Human Cardiac Microvascular Endothelial Cells Against Hypoxia/Reoxygenation-Induced Injury and Inflammatory Response by Activating PI3K/Akt/eNOS Signaling Pathway.

Applications

Unspecified application

Species

Unspecified reactive species

Hong-Hui Yang,Yan Chen,Chuan-Yu Gao,Zhen-Tian Cui,Jian-Min Yao

Molecular cell 65:999-1013.e7 PubMed28306514

2017

PARK2 Depletion Connects Energy and Oxidative Stress to PI3K/Akt Activation via PTEN S-Nitrosylation.

Applications

Unspecified application

Species

Unspecified reactive species

Amit Gupta,Sara Anjomani-Virmouni,Nikos Koundouros,Maria Dimitriadi,Rayman Choo-Wing,Adamo Valle,Yuxiang Zheng,Yu-Hsin Chiu,Sameer Agnihotri,Gelareh Zadeh,John M Asara,Dimitrios Anastasiou,Mark J Arends,Lewis C Cantley,George Poulogiannis
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com